Home›🔬 Science›How Continuous Glucose Monitoring Changed Type-2 Diabetes Management for Non-Diabetics

How Continuous Glucose Monitoring Changed Type-2 Diabetes Management for Non-Diabetics

ZakGT Science·By Sam Rivera·August 31, 2026·2.7K views
#science#medicine#2025#analysis#insights
📰
NEWS
📰
📰

NEWS

ZakGT Science

7 MIN READ
📢 Ad Space — BANNER (h-24)

Replication data is now available for a finding that generated significant coverage in 2023. The results are more nuanced than either the original celebration or the backlash coverage conveyed — and the nuance matters for how the finding should change behavior or policy.

Science coverage: Medicine continues to be one of the most-followed topics across ZakGT's global readership.

📢 Ad Space — RECTANGLE (w-[300px])

This report synthesizes the most relevant developments from primary sources, independent analysts, and on-the-ground correspondents, providing the signal-to-noise ratio that general news feeds cannot maintain.

📢 Ad Space — INLINE (h-20)

ZakGT editorial standard: every claim in this report links to a primary source. Reader feedback and corrections are reviewed by the editorial desk within 24 hours of publication.

📢 Ad Space — RECTANGLE (w-[300px])

Share this article

📖 More in Science

🔥 FEATURED
🔬 Science

Mars Water Ice at 30cm Depth: NASA's Perseverance Finding and What It Means for a 2035 Human Mission

Perseverance's ground-penetrating radar has confirmed water ice deposits beginning at just 30 centimeters below the Martian surface at two sites in Hellas Planitia — shallow enough to be accessible with current drilling technology. NASA's Jet Propulsion Lab confirms the finding changes the resource equation for sustained human presence: a crew of four could extract sufficient water for both consumption and electrolysis-based fuel production from a 200-meter drilling site without resupply from Earth.

Dr. Maria Santos·39m ago
👁 89.6K7m
🔬 Science

Sickle Cell CRISPR Trial: 18-Month Follow-Up Data Shows Complete Symptom Resolution in All 12 Patients

The CLIMB-SCD-121 trial's 18-month follow-up data, published in the New England Journal of Medicine, confirms that all 12 patients treated with the CTX001 CRISPR base-editing therapy have maintained complete resolution of vaso-occlusive crises — the debilitating pain episodes that define severe sickle cell disease. Hematologists not involved in the study describe the results as "the most compelling gene therapy outcome published in any blood disorder to date," while noting that 18-month follow-up cannot yet establish whether the benefit is permanent.

Dr. James Wu·1d ago
👁 67.8K8m
🔬 Science

Artemis IV: The Technical Challenges NASA Has Not Fully Solved Before the Moon Return

The methodology section of this research paper contains details that significantly affect how the findings should be interpreted. ZakGT Science explains what the peer reviewers required the authors to change and what the final study actually claims — which differs meaningfully from the press release.

Alex Carter·1h ago
👁 2.2K4m
🔬 Science

The Particle Physics Finding That Does Not Fit the Standard Model — and Why It Matters

The gap between the published finding and the popular coverage of it is larger than usual here. This report identifies exactly where the interpretation diverged from what the data supports, consults three independent researchers who were not involved in the study, and explains what the actual evidence supports.

Jordan Blake·2h ago
👁 2.4K5m
📢 Ad Space — FOOTER (h-16)